TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 139 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2015. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $3,000 | -92.1% | 5,244 | -81.2% | 0.00% | – |
Q1 2019 | $38,000 | +22.6% | 27,967 | +0.1% | 0.00% | – |
Q4 2018 | $31,000 | -60.3% | 27,934 | -0.6% | 0.00% | – |
Q3 2018 | $78,000 | -15.2% | 28,095 | +8.8% | 0.00% | – |
Q2 2018 | $92,000 | -5.2% | 25,819 | -18.7% | 0.00% | – |
Q1 2018 | $97,000 | -47.8% | 31,776 | +7.5% | 0.00% | – |
Q4 2017 | $186,000 | -36.7% | 29,555 | -31.4% | 0.00% | – |
Q3 2017 | $294,000 | +9.7% | 43,069 | +14.2% | 0.00% | – |
Q2 2017 | $268,000 | -60.5% | 37,704 | -48.9% | 0.00% | – |
Q1 2017 | $678,000 | +18.5% | 73,765 | -48.0% | 0.00% | – |
Q4 2016 | $572,000 | +940.0% | 141,966 | +895.6% | 0.00% | – |
Q3 2016 | $55,000 | -11.3% | 14,259 | -1.0% | 0.00% | – |
Q2 2016 | $62,000 | -24.4% | 14,402 | -18.3% | 0.00% | – |
Q1 2016 | $82,000 | -45.7% | 17,628 | +17.5% | 0.00% | – |
Q4 2015 | $151,000 | -4.4% | 15,008 | -29.1% | 0.00% | – |
Q3 2015 | $158,000 | -98.5% | 21,166 | -90.8% | 0.00% | -100.0% |
Q2 2015 | $10,882,000 | -27.0% | 229,396 | -43.6% | 0.00% | +33.3% |
Q1 2015 | $14,910,000 | +190.2% | 406,932 | +214.6% | 0.00% | +50.0% |
Q4 2014 | $5,137,000 | +16.7% | 129,355 | -41.4% | 0.00% | 0.0% |
Q3 2014 | $4,403,000 | -8.1% | 220,711 | -37.9% | 0.00% | 0.0% |
Q2 2014 | $4,793,000 | +14.7% | 355,294 | -7.4% | 0.00% | 0.0% |
Q1 2014 | $4,177,000 | +14.4% | 383,615 | +42.0% | 0.00% | 0.0% |
Q4 2013 | $3,652,000 | – | 270,129 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 354,300 | $7,068,000 | 2.77% |
Opaleye Management Inc. | 169,700 | $3,385,515,000 | 2.64% |
Broadfin Capital, LLC | 959,247 | $19,137,000 | 2.01% |
Novo Holdings A/S | 900,000 | $17,955,000 | 1.75% |
Eventide Asset Management | 300,900 | $6,003,000 | 0.84% |
EAM Investors, LLC | 152,595 | $3,044,000 | 0.62% |
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 497,858 | $9,932,000 | 0.51% |
Granite Point Capital Management, L.P. | 40,000 | $798,000 | 0.40% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,191 | $8,981,000 | 0.33% |
TFS CAPITAL LLC | 133,070 | $2,655,000 | 0.23% |